Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility study of dose-dense chemotherapy for primary breast cancer
jRCTs041180139Completed
- Start
- Jul 2017
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of doxorubicin, epirubicin, cyclophosphamide, paclitaxel and pegfilgrastim in breast cancer. Primary endpoints: Completion rate of treatment and Safety. Started Jul 2017; status: completed.
02
Drugs
doxorubicinepirubicincyclophosphamidepaclitaxelpegfilgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCTs041180139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180139.